Introduction
============

The prevalence of childhood obesity has been rising rapidly in recent years and is seen as a cause for alarm by public health agencies, health care clinicians, health care researchers and the general public ([@b1-jhk-29-67]). Using the standard *International Obesity Task Force* definition of pediatric obesity, the prevalence of obesity in children and young people aged 5--17 years worldwide is approximately 2--3% ([@b21-jhk-29-67]). Its impact on morbility, mortality and quality of life has made childhood obesity the epidemic of the XXI century ([@b50-jhk-29-67]) and a major public health problem ([@b51-jhk-29-67]). Childhood obesity is the commonest cause of such cardiovascular risk factors as hypertension, dyslipidemia and insulin resistance ([@b39-jhk-29-67]), the principal components of metabolic syndrome in children and adolescents ([@b49-jhk-29-67]). It is also an independent risk factor for obesity and increased health risks in adult life ([@b3-jhk-29-67]).

Recommendations for caloric intake and physical activity need to be reassessed and better quantified at a population level because of the sedentary lifestyles of today\'s children ([@b13-jhk-29-67]). For instance, recommendations regarding the treatment of childhood obesity focus typically on lifestyle changes, including increased physical activity and the promotion of healthy eating habits ([@b8-jhk-29-67]). An unbalanced diet and lack of physical activity cause excess fat storage in the child\'s adipose tissue ([@b52-jhk-29-67]) which in turn influences energy metabolism, insulin sensitivity ([@b16-jhk-29-67]), and other components of metabolic syndrome ([@b7-jhk-29-67]). While weight loss through diet favourably modifies various cardiovascular risk indicators including the lipid profile ([@b29-jhk-29-67]), it appears that this treatment usually fails to raise high density lipoprotein cholesterol (HDL) levels in obese children ([@b53-jhk-29-67]). Since diet alone reduces both fat mass and muscle density, additional physical exercise seems necessary to counterbalance this latter decline ([@b40-jhk-29-67]). Moreover, exercise improves insulin sensitivity ([@b15-jhk-29-67]) and blood lipid transport ([@b46-jhk-29-67]), and is able to reverse the metabolic effect on the muscle of obese subjects ([@b43-jhk-29-67]). In this sense, there is evidence that physical activity and physical exercise programs during the years of growth may be protective against future cardiovascular disease ([@b35-jhk-29-67]).

Despite extensive research on childhood obesity, there remains a lack of clear scientific evidence on the roles of diet and exercise in weight control, especially in children ([@b23-jhk-29-67]). A meta-analysis ([@b20-jhk-29-67]) concludes that a diet combined with exercises will help reduce low density lipoprotein (LDL) and triglyceride (TG) levels, but it also decreases HDL cholesterol when compared with a purely exercise-based intervention. However, there is insufficient quality data to allow one treatment program to be recommended over another ([@b31-jhk-29-67]). Other studies of obese children have shown that a combined diet and exercise intervention program lasting a relatively short time -- two ([@b2-jhk-29-67]; [@b9-jhk-29-67]) or three ([@b38-jhk-29-67]) months -- improved kinanthropometric (BMI and waist circumference) and metabolic (total cholesterol, LDL, and TG) variables. The aim of the present study was to determine the effects of implementing a medium-term (six-month) physical exercise and/or a diet program on the kinanthropometric and metabolic parameters of obese children.

Methods
=======

Subjects
--------

A total of 135 subjects were invited to participate through the collaboration of various schools in the town of Cáceres, Spain. The criterion for inclusion was that all participants had a body mass index (BMI) equal to or greater than the 97th percentile for the age and gender of the subject and ages between 8 and 11 years as defined by Spanish population curves ([@b14-jhk-29-67]). Subjects were excluded if they: (i) regularly practised some physical activity or were following some other therapy (n=65); (ii) were involved in any weight control program (n=18); (iii) took any medication (n=8); or (iv) had any type of dysfunction limiting their physical activity (n=2). The final sample consisted of 42 subjects (10.2±1.1 years). They were divided into three groups: the E group who followed a multi-sports exercise program (n = 11, 10.7±0.9 years, 8 boys and 3 girls), the D group who followed a low calorie diet (n=16, 10.1±1.3 years, 10 boys and 6 girls), and the E+D group who followed a combination of the two programs -- exercises and a low calorie diet (n=15, 10.1±1.0 years, 9 boys and 6 girls). There were no differences at the level of maturity whether between boys and girls of the same group (intragroup differences) or between boys and girls of the three groups (intergroup difference) ([Table 1](#t1-jhk-29-67){ref-type="table"}). This homogeneity at the stage of maturity allowed us to form groups with both sexes, as have previous studies ([@b32-jhk-29-67]; [@b5-jhk-29-67]). All the children\'s parents completed a prior informed consent form. The study was approved by the Bioethics Committee of the Universidad de Extremadura and respected the principles of the Declaration of Helsinki.

Measurements
------------

Kinanthropometric and metabolic parameters were evaluated for all subjects on the day before the intervention began, and at the beginning and end of the intervention. Pubertal stage was evaluated according to the Tanner classification ([@b44-jhk-29-67]). The kinanthropometric measurements followed the ISAK protocol ([@b30-jhk-29-67]): body height, body weight, BMI, waist circumference, hip circumference, waist/hip ratio, and body fat mass (bio-impedance) (there were no values for the diet group, the instrumentation was unavailable during their evaluation). Standard equipment was used: a scale-mounted stadiometer (Seca, Berlin, Germany), weight scale (Seca, Berlin, Germany), bio-impedance analyzer (Bodistat, Isle of Man, Great Britain), and a non-extensible measuring tape (Holtain, Crymych, Great Britain). A blood sample (20 ml) was collected from an antecubital vein between 8:30 and 9:30 a.m. after an overnight fast. The metabolic parameters measured were: plasma total cholesterol concentration (Chod-Pad assay, automatic analyzer), HDL (HDL-C plus assay, automatic analyzer), triglyceridemia (Chod-Pad assay, automatic analyzer), blood glucose (glucose HK assay, automatic analyzer), insulinemia (human insulin RIA kit, Linco Research, Missouri, USA), and systolic (SBP) and diastolic (DBP) blood pressure (OMRON RX, Matsusaka, Japan). The homeostasis model assessment of insulin resistance (HOMA-IR) was used to measure the changes in insulin sensitivity among the subjects, and was calculated using the following formula ([@b24-jhk-29-67]): fasting plasma insulin (μU/mL) × fasting plasma glucose (in mg/dL) ÷ 22.5 × 18.182. The following atherogenic indices were also calculated: LDL/HDL ratio and TC/HDL ratio.

Intervention
------------

Three interventions were tested: an exercise program (E group), a low calorie diet (D group), and the combination of the two (E+D group). The exercise program consisted of three weekly 90 min sessions. The sessions were held in a multi-sports hall, supervised by two MSc in Sports Science (AGH and ADM) and under the supervision of two PhD\'s (JMS and YE). The program comprised of a warm-up (15--20 min), a main part consisting of pre-sports and multi-sports games with a moderate to vigorous intensity aerobic component (60--65 min), and a cool-down (5--10 min). The intensity of the session was monitored by accelerometry to ensure that all the subjects performed the activities with the same intensity. A Caltrac accelerometer (Hemokinetics, Madison, WI, USA) was used, programmed to function as a physical activity monitor ([@b36-jhk-29-67]). This uni-axial accelerometer contains a piezoelectric bender element which assesses the intensity of movement in the vertical plane. Its validity has been demonstrated as a method for estimating energy expenditure in children ([@b22-jhk-29-67]), and has been used in other studies ([@b17-jhk-29-67]; [@b26-jhk-29-67]; [@b36-jhk-29-67]). A Caltrac accelerometer does not record such activities as rowing or swimming. However, no activity of this type was used either in the exercise program or in the subjects\' daily physical activity for the duration of the study. The low-calorie diet consisted of five balanced meals spread throughout the day, with an energy intake of 1500 kcal/day. In this sense, there have been studies that recommend diets of between 1500 and 1800 kcal/d in obese children who are still growing ([@b4-jhk-29-67]; [@b11-jhk-29-67]) since in this way their growth and development are not compromised ([@b10-jhk-29-67]). Thus the diet prescribed was of 1500 kcal/d, similar to that of other studies ([@b12-jhk-29-67]). This means a reduction of 400 kcal/d (22%), again a reduction similar to previous studies ([@b9-jhk-29-67]; [@b2-jhk-29-67]). The diet consisted of 57% carbohydrates, 17% proteins, and 26% fats. Foods were selected according to the subject's dietary habits. A series of general recommendations were established focused on basic healthy lifestyle eating: consume ≥ 5 servings of fruits and vegetables every day; minimize sugar-sweetened beverages such as soft drinks, sports drinks, and sugar-added fruit juices; have more meals prepared at home rather than purchasing take-away restaurant food; etc.

Statistical analysis
--------------------

All the variables satisfied the tests of homoskedasticity (Levene homogeneity test) and normality (Kolmogorov-Smirnov test) of their distributions. The basic descriptive statistics (mean and standard deviation) were calculated. A repeated-measure ANOVA was used to compare the interaction between the different groups (E, D, E+D group) and different times of the test (preand post-test). The Tukey *post-hoc* test was used to compare means. Cohen\'s categories were used for the magnitudes of the effect size: small if 0≤\|d\|≤0.2; medium if 0.2\<\|d\|≤0.5; and large if \|d\|\>0.5 ([@b6-jhk-29-67]). The level of significance for all statistical tests was set at p ≤ 0.05. All calculations were performed using SPSS (version 16.0).

Results
=======

There were no intergroup differences in the kinanthropometric and metabolic parameters before the program ([Table 1](#t1-jhk-29-67){ref-type="table"}).

There were differences in the kinanthropometric ([Table 2](#t2-jhk-29-67){ref-type="table"}) and metabolic ([Table 3](#t3-jhk-29-67){ref-type="table"}) parameters after the six-month interventions relative to baseline values in each group. While in the D group there were no significant changes in any of the kinanthropometric parameters, in the E group there were reductions in BMI (p=0.003) and body fat mass (p\<0.001), and in the E+D group there were reductions in BMI (p\<0.001), body fat mass (p=0.002), body weight (p=0.024), and waist (p\<0.001) and hip (p\<0.001) circumferences. With respect to the metabolic parameters, while the E group presented no change in any parameter, the D group presented reduced levels of TG (p=0.046), glucose (p=0.007), HOMA-IR (p\<0.001), SBP (p\<0.001), and DBP (p=0.050), and the E+D group presented improvements in HDL (p=0.038) and LDL (p=0.050) cholesterol, and in the LDL/HDL (p=0.009) and TC/HDL (p=0.004) ratios.

With respect to the group and time interaction in the kinanthropometric parameters ([Table 4](#t4-jhk-29-67){ref-type="table"}), differences were observed in body weight (D group\>E+D group; p=0.041; ES=0.30) (E group\>E+D group; p\<0.001; ES=0.67) and hip circumference (E group\>E+D group; p=0.004; ES=0.65). In the metabolic parameters ([Table 5](#t5-jhk-29-67){ref-type="table"}), there were differences in glucose (D group\<E+D group; p=0.010; ES=−0.86), LDL/HDL ratio (E group\>E+D group; p=0.007; ES=−0.03), and TC/HDL ratio (E group\>E+D group; p=0.019; ES=−0.10).

Discussion
==========

The present study has analyzed the medium-term (six months) effects on kinanthropometric and metabolic variables of an intervention based on exercise and/or a low calorie diet program. The mean participation of subjects in the exercise program was 81% (E group) and 83% (E+D group). Quantifying the intensities of 13 of the sessions selected at random showed no significant differences between the E and the E+D groups in any session, with a mean of 78.4 and 71.1 counts per session, respectively ([Figure 1](#f1-jhk-29-67){ref-type="fig"}). Not all the sessions were quantified since the programming and placement of the accelerometers meant taking time away from the physical exercise program. The use of accelerometers allows one to objectively quantify the subjects\' physical activity, ensuring that the intensity was similar in two groups. In developing treatment strategies for obesity, one requires quantitative information on physical activity to provide more effective goals ([@b18-jhk-29-67]), and, in so far as the methods used in the present work are concerned, this is the first study to have monitored physical activity sessions in an obese population using accelerometers.

Intragroup differences
----------------------

With respect to the intervention based solely on a physical exercise program (E group), there was a significant reduction in BMI (p=0.003) ([Table 3](#t3-jhk-29-67){ref-type="table"}). These findings, coherent with the literature ([@b5-jhk-29-67]; [@b38-jhk-29-67]), are indicative of the importance of physical exercise in regulating body weight. Not all the evidence points in the same direction, however, one published review suggests that exercise beneficially modifies body composition (fat and lean body mass) without changes in body weight or BMI in obese children ([@b48-jhk-29-67]). In this regard, there were improvements in body fat mass (E and E+D group, p\<0.001 and p=0.002, respectively), confirming that aerobic exercise can positively influence body composition ([@b48-jhk-29-67]). Some studies, however, find no improvement in this parameter ([@b2-jhk-29-67]; [@b5-jhk-29-67]; [@b9-jhk-29-67]; [@b38-jhk-29-67]). There were no significant changes in any metabolic parameter for this group. The lack of improvement in TC and LDL levels was probably because the subjects maintained their normal intake of fats ([@b40-jhk-29-67]). The results indicate that, once established, regular modest exercise can improve dyslipidemia ([@b5-jhk-29-67]). Although a short-term (three-month) intervention program (90 min/day for three days a week) has been reported as leading to significant improvements in TG concentrations ([@b38-jhk-29-67]), the initial values in that study were practically twice those of the present subjects. Neither did the E group\'s glucose levels improve, confirming that exercise alone is not always associated with changes in glucose metabolism ([@b48-jhk-29-67]).

The intervention based on a low calorie diet (D group) achieved no change in the kinanthropometric parameters after the six-month program ([Table 2](#t2-jhk-29-67){ref-type="table"}). Similar results were found in another study of shorter duration (six weeks), but of greater dietary restriction (between 900 and 1200 kcal/day) ([@b42-jhk-29-67]). In contrast, another intervention of longer duration (12 weeks) and similar diet (1200 kcal/day) significantly reduced the BMI and waist circumference ([@b38-jhk-29-67]). Regarding the metabolic parameters in the D group, there was a significant reduction in blood TG (p=0.046) and glucose (p=0.007). According to *The National Cholesterol Education Program*, a hypocaloric diet (30% or less of calories as total fat) reduces TC and LDL levels in normolipidæmic and hypercholesterolæmic subjects ([@b37-jhk-29-67]), with a smaller effect on TG and HDL ([@b47-jhk-29-67]). Presented results did not confirm these findings. Although there was a downward trend in these parameters after the intervention ([Table 3](#t3-jhk-29-67){ref-type="table"}), the subjects presented normal mean values ([@b28-jhk-29-67]). It is important to note that the TG concentration is influenced by, among other factors, the amount and quality of the carbohydrates and fats ingested, with the recommendation being to reduce the consumption of saturated fats and cholesterol, and of simple sugars or other carbohydrates of high glycæmic index ([@b25-jhk-29-67]). Thus, the increased consumption of fruits and vegetables that were included in the diet could explain this reduction in TG ([@b19-jhk-29-67]). The observed decrease in HOMA-IR (p\<0.001), which is associated with improved insulin sensitivity ([@b32-jhk-29-67]) may also play a major role in reducing TG ([@b5-jhk-29-67]). Although such an improvement in insulin sensitivity has at times been associated with decreased body fat ([@b33-jhk-29-67]), our data showed this improvement without any such significant decline. Finally, this intervention program (D group) reduced the blood pressure, both SBP (p\<0.001) and DBP (p=0.050), suggesting that such blood pressure reduction is associated with sympathetic neurovascular attenuation ([@b33-jhk-29-67]).

In the intervention which combined exercise and a low calorie diet (E+D group), improvements were observed in kinanthropometric parameters, with reductions in body weight (p=0.024), BMI (p\<0.001), waist (p\<0.001) and hip (p\<0.001) circumferences, and body fat mass (p=0.002) ([Table 2](#t2-jhk-29-67){ref-type="table"}). These results are coherent with those of a previous study of less duration -- two months (90 min/day for four days a week) and individual diet (−500 kcal/day below the initial dietary records) ([@b9-jhk-29-67]). Both studies show that a combined program of exercise and a low calorie diet contributes effectively to the prevention of obesity in children, probably because this strategy increases fat oxidation during exercise ([@b34-jhk-29-67]). Moreover, this intervention (E+D group) increased HDL (p=0.038), and decreased LDL (p=0.050) cholesterol and the LDL/HDL (p=0.009) and TC/HDL (p=0.004) ratios ([Table 3](#t3-jhk-29-67){ref-type="table"}), in agreement with the results of similar studies ([@b2-jhk-29-67]). In this regard, a combination therapy of diet plus exercise develops aerobic capacity, thus improving glucose tolerance and the lipoprotein profiles, and reducing the risk of coronary heart disease ([@b32-jhk-29-67]).

Intergroup differences
----------------------

The results showed that subjects benefited more from the combined program (E+D group) than from the physical exercise alone (E group) or the low calorie diet alone (D group) by better managing their body composition ([Table 4](#t4-jhk-29-67){ref-type="table"}). In particular, the E+D group achieved weight reduction relative to the D group (p=0.041; ES=0.30; 95% CI, −0.41 to 1.01), and even more markedly relative to the E group (p\<0.001; ES=0.67; 95% CI, −0.14 to 1.47). This is a positive finding since a study ([@b48-jhk-29-67]) has suggested that a combination of dietary and exercise treatments individually designed for the specific pathological conditions of obese children facilitates the selective reduction of body fat, while maintaining the amount of muscle of the entire body. The E+D group also presented differences in hip circumference relative to the E group (p=0.004; ES=0.65; 95% CI, −0.15 to 1.45), showing that exercise alone does not consistently decrease body weight or fat distribution ([@b47-jhk-29-67]). With respect to metabolic parameters ([Table 5](#t5-jhk-29-67){ref-type="table"}), the glucose levels of the D group were lower than those of the E+D group (p=0.010; ES=−0.86; 95% CI, −1.60 to −0.12). No differences were observed, however, in insulin or HOMA-IR, although the values of both groups were within the normal range (Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003). The combined treatment (E+D group) led to greater changes than exercise alone (E group) in the LDL/HDL (p=0.007; ES=−0.03; 95% CI, −0.80 to 0.68) and TC/HDL (p=0.019; ES=−0.10; 95% CI, −0.88 to 0.68) ratios. It has been suggested that these indicators are better predictors of the reduction of cardiovascular disease risk than HDL, LDL, or TC values on their own ([@b27-jhk-29-67]), which could indicate that this combined treatment is more effective in controlling dyslipidemia than exercise alone. Although other studies do not in general observe these differences between one treatment and another ([@b31-jhk-29-67]), the present results clearly show the importance of the dietary component in the treatment of subjects with childhood obesity ([@b38-jhk-29-67]).

Limitations
-----------

A number of limitations of this study need to be kept in mind. First, there was a lack of initial randomization of the groups. Several subjects ate at the school\'s refectory, or were unable to attend the exercise program, making it impossible to randomly assign membership to one or another group. Nonetheless, the homogeneity of the groups was verified by the absence of initial differences in any of the variables ([Table 1](#t1-jhk-29-67){ref-type="table"}). Second, the duration of the intervention was only medium-term. Indeed, this was a pilot study for a subsequent longitudinal analysis of the parameters being monitored over the following three years, and then a follow-up study in the fourth year, an aspect of importance in children with this condition ([@b41-jhk-29-67]). Third, the sample was comprised of both boys and girls, although there were no intergroup or intragroup differences at the stage of maturity ([Table 1](#t1-jhk-29-67){ref-type="table"}) which allowed us to form groups with children of both sexes, since this choice would not affect the study. Finally, if the number of subjects had been greater the results would of course have been more convincing. However, the sample may be considered acceptable for the purposes of the present work since there have been studies in this area working with samples of similar sizes ([@b33-jhk-29-67]; [@b2-jhk-29-67]; [@b9-jhk-29-67]).

Conclusion
==========

A medium-term intervention based on the combination of a low calorie diet and exercise in obese children showed improvements in kinanthropometric and metabolic parameters, especially in those related to the lipid profile. The interventions based on exercise alone or low calorie diet only achieved improvements in certain metabolic or kinanthropometric variables, respectively. The combined intervention, a low calorie diet plus exercise, was more effective in controlling body weight than either type of intervention alone. Similarly, there were no differences in effectiveness between the two interventions, exercise and low calorie diet, carried out alone, highlighting the need to combine the two to improve the kinanthropometric and metabolic parameters of obese children.
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###### 

Pubertal status (mean ± SD) and intergroup (boys and girls) and intragroup (boys vs girls) differences

  Pubertal status            E group (n=11)   D group (n=16)   E+D group (n=15)   Intergroup differences   
  -------------------------- ---------------- ---------------- ------------------ ------------------------ -------
  Tanner stage -- boys       1.88 ± 0.6       1.80 ± 0.6       2.00 ± 0.5         0.271                    0.765
  Tanner stage -- girls      2.33 ± 0.6       1.83 ± 0.7       1.67 ± 0.8         0.790                    0.476
                                                                                                           
  Intragroup differences                                                                                   
    F-value, boys vs girls   1.604            0.135            0.371                                       
    p-value, boys vs girls   0.237            0.719            0.553                                       

###### 

Anthropometric characteristics of the study participants (mean and standard deviation pre- and post-test, inter- and intra-group differences)

  Variable                             E group (n=11)   D group (n=16)   E+D group (n=15)   Intergroup differences (p-value)
  ------------------------------------ ---------------- ---------------- ------------------ ----------------------------------
  Height (m)                                                                                P
    Baseline                           1.49 ± 0.1       1.44 ± 0.1       1.47 ± 0.1         0.779
    6 months                           1.52 ± 0.1       1.47 ± 0.1       1.49 ± 0.1         0.283
    Intragroup differences (p-value)   **\<0.001**      **\<0.001**      **\<0.001**        
  Weight (kg)                                                                               
    Baseline                           61.9 ± 10.2      58.9 ± 12.4      57.6 ± 11.2        0.501
    6 months                           62.7 ± 9.8       59.2 ± 13.6      55.3 ± 11.4        **0.008**
    Intragroup differences (p-value)   0.168            0.745            **0.024**          
  BMI, (kg/m^2^)                                                                            
    Baseline                           27.8 ± 3.5       28.5 ± 5.2       26.8 ± 3.5         0.106
    6 months                           27.0 ± 3.2       27.3 ± 5.6       24.7 ± 3.5         0.518
    Intragroup differences (p-value)   **0.003**        0.300            **\<0.001**        
  Waist (cm)                                                                                
    Baseline                           94.7 ± 8.3       91.7 ± 10.9      90.7 ± 7.9         0.632
    6 months                           94.0 ± 7.8       89.8 ± 11.0      86.8 ± 9.2         0.120
    Intragroup differences (p-value)   0.614            0.130            **\<0.001**        
  Hip (cm)                                                                                  
    Baseline                           95.8 ± 8.3       97.4 ± 10.4      94.7 ± 8.1         0.488
    6 months                           96.6 ± 6.3       96.2 ± 10.2      91.2 ± 9.1         **0.006**
    Intragroup differences (p-value)   0.459            0.176            **\<0.001**        
  Waist/hip                                                                                 
    Baseline                           0.98 ± 0.15      0.94 ± 0.49      0.96 ± 0.35        0.181
    6 months                           0.97 ± 0.46      0.93 ± 0.42      0.95 ± 0.36        0.747
    Intragroup differences (p-value)   0.205            0.264            0.175              
  Body fat mass (%)                                                                         
    Baseline                           25.4 ± 6.92      \-               25.7 ± 5.94        0.853
    6 months                           24.0 ± 6.41      \-               22.4 ± 5.97        0.083
    Intragroup differences (p-value)   **\<0.001**      \-               **0.002**          

The body fat mass data of the diet group were lost and hence could not be included in the analysis

###### 

Metabolic characteristics of the study participants (mean and standard deviation pre- and post-test, inter- and intra-group differences)

  Variable                             E group (n=11)   D group (n=16)   E+D group (n=15)   Intergroup differences (p-value)
  ------------------------------------ ---------------- ---------------- ------------------ ----------------------------------
  TC (mg/dl)                                                                                
    Baseline                           170.2 ± 15.2     173.6 ± 26.4     163.9 ± 21.9       0.432
    6 months                           169.8 ± 14.6     169.7 ± 20.9     158.0 ± 16.9       0.599
    Intragroup differences (p-value)   0.920            0.215            0.153              
  HDL (mg/dl)                                                                               
    Baseline                           51.0 ± 7.4       47.1 ± 12.0      41.8 ± 10.5        0.395
    6 months                           50.3 ± 11.3      48.4 ± 12.1      46.2 ± 14.5        0.148
    Intragroup differences (p-value)   0.761            0.339            **0.038**          
  LDL (mg/dl)                                                                               
    Baseline                           106.4 ± 16.7     108.1 ± 26.4     107.8 ± 14.6       0.315
    6 months                           107.2 ± 16.9     107.2 ± 20.1     98.1 ± 17.2        0.109
    Intragroup differences (p-value)   0.811            0.654            **0.050**          
  TG (mg/dl)                                                                                
    Baseline                           64.8 ± 27.5      85.6 ± 71.3      75.8 ± 50.5        0.569
    6 months                           61.5 ± 20.2      63.6 ± 28.9      64.5 ± 32.7        0.617
    Intragroup differences (p-value)   0.920            **0.046**        0.394              
  Insulin (μU/ml)                                                                           
    Baseline                           14.1 ± 8.3       21.9 ± 16.3      12.4 ± 7.9         0.308
    6 months                           11.4 ± 5.1       17.5 ± 13.7      9.1 ± 2.7          0.944
    Intragroup differences (p-value)   0.202            0.320            0.123              
  Glucose (mg/dl)                                                                           
    Baseline                           90.4 ± 5.5       86.8 ± 6.1       85.9 ± 4.9         0.422
    6 months                           90.4 ± 3.6       83.2 ± 5.5       88.1 ± 5.6         **0.034**
    Intragroup differences (p-value)   1.000            **0.007**        0.302              
  HOMA-IR                                                                                   
    Baseline                           3.15 ± 2.1       3.49 ± 2.6       2.05 ± 1.8         0.331
    6 months                           2.53 ± 1.2       1.41 ± 2.6       2.42 ± 1.6         **0.011**
    Intragroup differences (p-value)   0.208            **\<0.001**      0.902              
  LDL/HDL                                                                                   
    Baseline                           2.12 ± 0.43      2.46 ± 0.99      2.69 ± 0.66        0.426
    6 months                           2.28 ± 0.82      2.39 ± 0.84      2.30 ± 0,70        **0.009**
    Intragroup differences (p-value)   0.283            0.326            **0.009**          
  TC/HDL                                                                                    
    Baseline                           3.38 ± 0,46      3.94 ± 1.25      4.11 ± 0.87        0.479
    6 months                           3.54 ± 0.86      3.72 ± 1.02      3.63 ± 0.83        **0.025**
    Intragroup differences (p-value)   0.319            0.141            **0.004**          
  SBP (mm Hg)                                                                               
    Baseline                           111.8 ± 9.6      122.9 ± 8.9      117.9 ± 7.4        0.097
    6 months                           108.4 ± 11.2     111.4 ± 8.1      113.9 ± 7.4        0.157
    Intragroup differences (p-value)   0.080            **\<0.001**      0.197              
  DBP (mm Hg)                                                                               
    Baseline                           65.3 ± 7.3       63.7 ± 7.9       66.9 ± 8.9         0.672
    6 months                           65.5 ± 8.2       57.0 ± 8.5       65.1 ± 6.1         0.410
    Intragroup differences (p-value)   0.881            **0.050**        0.277              

TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglycerides; HOMA-IR, homœostasis model assessment index for insulin resistance; SBP=systolic blood pressure; DBP=diastolic blood pressure

###### 

Differences between groups for the changes in anthropometric variables (mean and standard deviation, 95% confidence interval, and effect size)

  Variable                E group (n=11)   D group (n=16)   E+D group (n=15)   Differences between groups                                                                           
  ----------------------- ---------------- ---------------- ------------------ ---------------------------- ------------ ------------ ------ ------ ---------- --------- ---------- ---------
  Δ Weight (kg)                                                                                                                                                                     
    Baseline - 6 months   0.9 ± 1.9        −0.4, 2.2        0.1 ± 3.1          −1.6, 1.7                    −2.4 ± 2.5   −3.7, −1.0   0.69   0.3    **0.01**   **0.7**   **0.04**   **0.3**
  Δ BMI (kg/m^2^)                                                                                                                                                                   
    Baseline - 6 months   −0.6 ± 1.0       −1.3, −0.1       −1.3 ± 4.5         −3.7, 1.1                    −2.1 ± 1.0   −2.7, −1.5   0.89   0.2    0.47       0.7       0.77       0.4
  Δ Waist (cm)                                                                                                                                                                      
    Baseline - 6 months   −0.6 ± 4.1       −3.4, 2.1        −1.9 ± 4.8         −4.4, 0.6                    −3.9 ± 3.1   −5.6, −2.2   0.65   0.4    0.11       0.8       0.40       0.3
  Δ Hip (cm)                                                                                                                                                                        
    Baseline - 6 months   0.6 ± 3.7        −1.9, 3.1        −1.0 ± 3.5         −2.8, 0.8                    −3.5 ± 2.6   −4.9, −2.0   0.22   −0.6   **0.01**   **0.7**   0.15       0.5
  Δ Waist/hip (cm)                                                                                                                                                                  
    Baseline - 6 months   −0.1 ± 0.1       −0.1, 0.1        −0.1 ± 0.3         −0.1, 0.1                    −0.1 ± 0.2   −0.2, 0.0    0.81   0.1    0.75       0.1       0.99       −0.1
  Δ Body fat (%)                                                                                                                                                                    
    Baseline - 6 months   −1.4 ± 0.9       −2.0, −0.7       \-                 \-                           −3.3 ± 3.3   −5.2, −1.4   \-     \-     0.08       0.3       \-         \-

BMI, body mass index; CI, confidence interval; ES, effect size

###### 

Differences between groups for the changes in metabolic variables (mean and standard deviation, 95% confidence interval and effect size)

  Variable                E group (n=11)   D group (n=16)   E+D group (n=15)   Differences between groups                                                                               
  ----------------------- ---------------- ---------------- ------------------ ---------------------------- -------------- ------------- ------ ------ ---------- ---------- ---------- ----------
  Δ TC (mg/dl)                                                                                                                                                                          
    Baseline - 6 months   0.0 ±12.1        −8.1, 8.1        −4.6 ± 16.4        −13.3, 4.2                   −5.9 ± 11.6    −12.3, 0.6    0.79   0.1    0.50       0.7        0.84       0.6
  Δ HDL (mg/dl)                                                                                                                                                                         
    Baseline - 6 months   −1.1 ± 6.7       −5.6, 3.4        1.6 ± 5.8          −1.5, 4.7                    4.4 ± 6.5      0.6, 8.1      0.73   0.2    0.22       0.3        0.53       0.2
  Δ LDL (mg/dl)                                                                                                                                                                         
    Baseline - 6 months   0.8 ± 11.1       −6.6, 8.3        −0.8 ± 14.6        −8.6, 9.0                    −9.8 ± 11.72   −17.2, 2.3    0.94   0.01   0.13       −0.1       0.18       −0.1
  Δ TG (mg/dl)                                                                                                                                                                          
    Baseline - 6 months   −3.3 ± 25.4      −20.4, 13.8      −22.0 ± 56.0       −51.9, 7.9                   −11.3 ± 52.6   −43.1, 20.5   0.59   −0.1   0.91       −0.5       0.83       −0.4
  Δ Insulin (μU/mL                                                                                                                                                                      
    Baseline - 6 months   −2.6 ± 6.4       −6.9, 1.7        −4.5 ± 8.3         −13.1, 4.2                   −3.3 ± 6.9     −8.3, 1.6     0.87   −0.5   0.97       −0.3       0.95       0.5
  Δ Glucose (mmol/L)                                                                                                                                                                    
    Baseline - 6 months   0.0 ± 4.6        −3.1, 3.1        −3.6 ± 5.2         −6.4, −0.9                   2.2 ± 5.0      −0.9, 5.2     0.17   1.5    0.55       0.1        **0.01**   **−0.9**
  Δ HOMA-IR                                                                                                                                                                             
    Baseline - 6 months   −0.8 ± 1.4       −1.7, 0.2        −2.0 ± 1.7         −2.9, −1.0                   0.1 ± 2.5      −1.3, 1.6     0.84   0.5    0.99       0.3        0.78       −0.3
  Δ LDL/HDL                                                                                                                                                                             
    Baseline - 6 months   0.2 ± 0.5        −0.1, 0.6        −0.1 ± 0.4         −0.3, 0.1                    −0.4 ± 0.3     −0.8, −0.2    0.35   −0.1   **0.01**   **−0.1**   0.12       −0.4
  Δ TC/HDL                                                                                                                                                                              
    Baseline - 6 months   0.2 ± 0.5        −0.1, 0.6        −0.3 ± 0.7         −0.6, 0.1                    −0.48 ± 0.39   −0.7, −0.3    0.21   −0.2   **0.02**   **−0.1**   0.41       −0.3
  Δ SBP (mm Hg)                                                                                                                                                                         
    Baseline - 6 months   −3.4 ± 5.7       −7.2, 0.5        −11.4 ± 10.2       −16.9, −6.0                  −3.9 ± 10.6    −9.8, 1.9     0.09   −0.3   0.99       −1.0       0.08       −0.8
  Δ DBP (mm Hg)                                                                                                                                                                         
    Baseline - 6 months   0.3 ± 5.9        −3.7, 4.2        −6.7 ± 11.1        −12.6, −0.8                  −1.74 ± 6.6    −5.4, 1.9     0.11   1.0    0.82       −0.2       0.23       −1.3

TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglycerides; HOMA-IR, homœostasis model assessment index for insulin resistance; SBP, systolic blood pressure; DBP, diastolic blood pressure; CI, confidence interval; ES=effect size

[^1]: Authors submitted their contribution of the article to the editorial board.
